Age‐Related Changes in β‐Adrenergic Neuroeffector Systems in the Human Heart

BackgroundAging decreases cardiac β–adrenergic responsiveness in model systems and in humans in vivo. The purpose of this study was to comprehensively evaluate the age-related changes in the β-receptor-G protein-adenylyl cyclase complex in nonfailing human hearts. Methods and ResultsTwenty-six nonfailing explanted human hearts aged 1 to 71 years were obtained from organ donors and subjected to pharmacological investigation of β-adrenergic neuroeffector systems. When the population was subdivided into the 13 youngest and 13 oldest subjects, total β-receptor density assessed by maximum [125I]ICYP binding (βmax) was reduced in older hearts by 37% in left ventricles and 31 % in right ventricles (both P<.05), and the downregulation was confined to the β1 subtype (r= −.78 left ventricle β1 density versus donor age). Older donor hearts exhibited a 3- to 4-fold rightward shift of ICYP-isoproterenol (ISO) competition curves and demonstrated 43% fewer receptors in a high-affinity agonist binding state (P<.05). Older hearts exhibited decreased adenylyl cyclase stimulation by ISO, by zinterol (β2-agonist), and by the G protein–sensitive probes forskolin, Gpp(NH)p, and NaF. In contrast, there was no change in response to manganese, a specific activator of the adenylyl cyclase catalytic subunit. Toxin-catalyzed ADP ribosylation in membranes prepared from older versus younger hearts revealed a 29% to 30% reduction (P<.05) with cholera toxin (Gβs) but no difference with pertussis toxin (Gβi). The systolic contractile response of isolated right ventricular trabeculae to ISO was decreased by 46%, with a 10-fold increase in ISO EC50 in older relative to younger donor hearts. ConclusionsThere is a profound decrease in cardiac β-adrenergic responsiveness with aging. This occurs by multiple mechanisms including downregulation and decreased agonist binding of β1-receptors, uncoupling of β2-receptors, and abnormal G protein-mediated signal transduction.

[1]  Y. Shu,et al.  Forskolin Binding Sites and G‐Protein Immunoreactivity in Rat Hearts During Aging , 1994, Journal of cardiovascular pharmacology.

[2]  D. Renlund,et al.  Up-regulation of beta 2-adrenergic receptors in previously transplanted, denervated nonfailing human hearts. , 1993, Journal of the American College of Cardiology.

[3]  H. Bourne,et al.  Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha. , 1993, The Journal of biological chemistry.

[4]  M. Y. Degtyarev,et al.  Increased palmitoylation of the Gs protein alpha subunit after activation by the beta-adrenergic receptor or cholera toxin. , 1993, The Journal of biological chemistry.

[5]  A. Ng,et al.  Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. , 1993, Hypertension.

[6]  D. Bernstein,et al.  Alteration in Gs-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. , 1993, Journal of Biological Chemistry.

[7]  M. Cerqueira,et al.  Differences in Cardiovascular Responses to Isoproterenol in Relation to Age and Exercise Training in Healthy Men , 1992, Circulation.

[8]  John O. Holloszy,et al.  Effects of Aging, Sex, and Physical Training on Cardiovascular Responses to Exercise , 1992, Circulation.

[9]  S. Pyne,et al.  Phosphorylation of the recombinant spliced variants of the alpha-sub-unit of the stimulatory guanine-nucleotide binding regulatory protein (Gs) by the catalytic sub-unit of protein kinase A. , 1992, Biochemical and biophysical research communications.

[10]  A. Branzi,et al.  Biochemical correlates with myocardial aging. , 1992, Cardioscience.

[11]  F. del Monte,et al.  Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response. , 1992, Journal of molecular and cellular cardiology.

[12]  J. Port,et al.  Effect of Therapeutic Dopamine Administration on Myocardial Catecholamine and Neuropeptide Y Concentrations in the Failing Ventricles of Patients with Idiopathic Dilated Cardiomyopathy , 1992, Journal of Cardiovascular Pharmacology.

[13]  L. Mestroni,et al.  Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. , 1992, The Journal of clinical investigation.

[14]  D. Kass,et al.  Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. , 1992, Circulation research.

[15]  M. Michel,et al.  Spare Receptors for β‐Adrenoceptor-Mediated Positive Inotropic Effects of Catecholamines in the Human Heart , 1992, Journal of cardiovascular pharmacology.

[16]  J. Port,et al.  Myocardial Catecholamine and Neuropeptide Y Depletion in Failing Ventricles of Patients With Idiopathic Dilated Cardiomyopathy: Correlation With β‐Adrenergic Receptor Downregulation , 1992, Circulation.

[17]  J. Rouleau,et al.  Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. , 1991, Journal of the American College of Cardiology.

[18]  J. Halter,et al.  Effect of desipramine on norepinephrine metabolism in humans: interaction with aging. , 1991, The American journal of physiology.

[19]  D. Kitzman,et al.  Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. , 1991, Journal of the American College of Cardiology.

[20]  A. Feldman,et al.  Immunodetectable levels of the inhibitory guanine nucleotide-binding regulatory proteins in failing human heart: discordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. , 1991, Journal of molecular and cellular cardiology.

[21]  D. Ferguson,et al.  Resting muscle sympathetic nerve activity correlates with right rather than left ventricular ejection fraction in human heart failure , 1991 .

[22]  M. White,et al.  Cardiac beta receptors and baroreflex responses with aging , 1991 .

[23]  P. Armstrong,et al.  Fibrillar collagen and remodeling of dilated canine left ventricle. , 1990, Circulation.

[24]  F. Romano,et al.  Increased myocardial adenosine production and reduction of beta-adrenergic contractile response in aged hearts. , 1990, Circulation research.

[25]  K. Shigenobu,et al.  Role of β‐adrenoceptor‐adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart , 1990, British journal of pharmacology.

[26]  P. Scarpace Forskolin activation of adenylate cyclase in rat myocardium with age: Effects of guanine nucleotide analogs , 1990, Mechanisms of Ageing and Development.

[27]  S. Vatner,et al.  Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor. , 1989, The Journal of clinical investigation.

[28]  R. Hershberger,et al.  Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density. , 1989, Circulation research.

[29]  E. Lakatta,et al.  Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. , 1989, The American journal of physiology.

[30]  W. Simonds,et al.  Receptor and effector interactions of Gs Functional studies with antibodies to the αs carboxyl‐terminal decapeptide , 1989, FEBS letters.

[31]  M. Bristow,et al.  Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes? , 1989, European heart journal.

[32]  E. Sonnenblick,et al.  Effects of age on mechanical and structural properties of myocardium of Fischer 344 rats. , 1989, The American journal of physiology.

[33]  J. Port,et al.  Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. , 1989, Molecular pharmacology.

[34]  A. Katz,et al.  The myocardium in congestive heart failure. , 1989, The American journal of cardiology.

[35]  W. Baumgartner,et al.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.

[36]  J. J. Beckeringh,et al.  Selective regulation of β1‐and β2‐adrenoceptors in the human heart by chronic β‐adrenoceptor antagonist treatment , 1988 .

[37]  M. Bristow,et al.  Myocardial α- and β-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? , 1988 .

[38]  H. Bittiger,et al.  CGP 20712 A: a useful tool for quantitating β1- and β2-adrenoceptors , 1986 .

[39]  M. Dufau,et al.  Inhibitory action of forskolin on adenylate cyclase activity and cyclic AMP generation. , 1986, The Journal of biological chemistry.

[40]  T. Miller,et al.  Left ventricular diastolic filling and its association with age. , 1986, The American journal of cardiology.

[41]  S. Jamieson,et al.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.

[42]  A. Gilman,et al.  Molecular basis for two forms of the G protein that stimulates adenylate cyclase. , 1986, The Journal of biological chemistry.

[43]  P. de Neef,et al.  Alterations of rat cardiac adenylate cyclase activity with age. , 1986, European journal of pharmacology.

[44]  R. Coleman,et al.  Physiologic basis for the age-related decline in aerobic work capacity. , 1986, The American journal of cardiology.

[45]  O. Brodde,et al.  Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. , 1986, Science.

[46]  J. Roberts,et al.  The Effect of Age on the Tyramine-Sensitive Intraneuronal Pool of Norepinephrine in Rat Heart , 1986, Journal of cardiovascular pharmacology.

[47]  J. Fleg,et al.  Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males. , 1985, Journal of applied physiology.

[48]  R. Ebstein,et al.  Deterioration of beta-receptor-adenylate cyclase function in elderly, hospitalized patients. , 1984, Journal of gerontology.

[49]  M. Bristow,et al.  Pharmacology and inotropic potential of forskolin in the human heart. , 1984, The Journal of clinical investigation.

[50]  M. Caron,et al.  Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. , 1984, Physiological reviews.

[51]  R. Feldman,et al.  Alterations in leukocyte β-receptor affinity with aging: a potential explanation for altered β-adrenergic sensitivity in the elderly , 1984 .

[52]  J. Fleg,et al.  Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. , 1984, Circulation.

[53]  J. Pitha,et al.  Decreased response with age of the cardiac catecholamine sensitive adenylate cyclase system. , 1983, Life sciences.

[54]  L. Rubenstein,et al.  Plasma norepinephrine responses to posture and isometric exercise increase with age in the absence of obesity. , 1983, Journal of gerontology.

[55]  I. Abrass,et al.  Catalytic unit of adenylate cyclase: reduced activity in aged-human lymphocytes. , 1982, The Journal of clinical endocrinology and metabolism.

[56]  L. Mahan,et al.  Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. , 1982, The Journal of biological chemistry.

[57]  J. Kelly,et al.  Human Lymphocyte β‐Adrenoceptor Density in Relation to Age and Hypertension , 1982 .

[58]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[59]  J. Kelly,et al.  Sodium fluoride activation of human lymphocyte adenylate cyclase is reduced in old age. , 1982, British journal of clinical pharmacology.

[60]  N. Narayanan,et al.  Alterations in the properties of β-adrenergic receptors of myocardial membranes in aging: Impairments in agonist—receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylated cyclase , 1982, Mechanisms of Ageing and Development.

[61]  R. Landmann,et al.  High affinity beta-2-adrenergic receptors in mononuclear leucocytes: similar density in young and old normal subjects. , 1981, Life sciences.

[62]  J. Kelly,et al.  Lymphocyte cyclic AMP production in the elderly: the effects of prostaglandin E1. , 1981, British journal of clinical pharmacology.

[63]  E. Braunwald,et al.  Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. , 1981, The New England journal of medicine.

[64]  D. Robertson,et al.  Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. , 1981, The Journal of clinical investigation.

[65]  I. Abrass,et al.  Age-associated decrease of adenylate cyclase activity in rat myocardium , 1981, Mechanisms of Ageing and Development.

[66]  I. Abrass,et al.  Human lymphocyte beta-adrenergic receptors are unaltered with age. , 1981, Journal of gerontology.

[67]  J. Krall,et al.  Age-related elevation of plasma catecholamine concentration and reduced responsiveness of lymphocyte adenylate cyclase. , 1981, The Journal of clinical endocrinology and metabolism.

[68]  J. L. Martínez,et al.  Age-related changes in the catecholamine content of peripheral organs in male and female F344 rats. , 1981, Journal of gerontology.

[69]  E. Rappaport,et al.  Impact of age on basal and diet-induced changes in sympathetic nervous system activity of Fischer rats. , 1981, Journal of gerontology.

[70]  A. Gilman,et al.  Purification of the regulatory component of adenylate cyclase. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[71]  E. Neer,et al.  Properties of the separated catalytic and regulatory units of brain adenylate cyclase. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[72]  E. Lakatta,et al.  Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart. , 1980, The American journal of physiology.

[73]  K. O'malley,et al.  Age and beta adrenoceptor–mediated function , 1980, Clinical pharmacology and therapeutics.

[74]  R. Vestal,et al.  Reduced β‐adrenoceptor sensitivity in the elderly , 1979 .

[75]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[76]  G. Peterson,et al.  A simplification of the protein assay method of Lowry et al. which is more generally applicable. , 1977, Analytical biochemistry.

[77]  E. Lakatta,et al.  Echocardiographic Assessment of a Normal Adult Aging Population , 1977, Circulation.

[78]  I. Kopin,et al.  Plasma noradrenaline increases with age , 1976, Nature.

[79]  W Grossman,et al.  Wall stress and patterns of hypertrophy in the human left ventricle. , 1975, The Journal of clinical investigation.

[80]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[81]  J. Covell,et al.  Left Ventricular Dilatation and Diastolic Compliance Changes during Chronic Volume Overloading , 1972, Circulation.

[82]  E. Braunwald,et al.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.

[83]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[84]  A. Wellstein,et al.  Differentiation of β1- and β2-adrenoceptor-mediated effects in humans , 1988 .

[85]  S. Banerjee,et al.  Age-related reduction of beta-adrenoceptor sensitivity in rat heart occurs by multiple mechanisms. , 1985, Gerontology.

[86]  G. Piazzesi,et al.  Influences of age on the positive inotropic effect mediated by alpha- and beta-adrenoceptors in rat ventricular strips. , 1985, Developmental pharmacology and therapeutics.

[87]  G. Piazzesi,et al.  Influences of age on the positive inotropic effect mediated by α- and β-adrenoceptors in rat ventricular strips , 1985 .

[88]  M. Laks,et al.  Norepinephrine increases beta-receptors and adenylate cyclase in canine myocardium. , 1984, The American journal of physiology.

[89]  O. Brodde Endogenous and Exogenous Regulation of Human α- and β-Adrenergic Receptors , 1983 .

[90]  N. Narayanan,et al.  Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. , 1982, Mechanisms of ageing and development.

[91]  B. Wallin,et al.  Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. , 1981, Acta physiologica Scandinavica.